Table 1 Characteristics of studies on correlation between high urate levels or gout and the risk of PD.

From: Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease

First author, year

Country

Case/total

Gender

Age

Follow-up years

PD definition

Adjustment for confounders

Newcastle-Ottawa scale

Cohort study for gout and PD incidence

De Vera, 200819

Canada

1182/67457

M/W

74.1

8

The ICD-9 code

Age, sex, hypertension, diabetes, hyperlipidemia, COPD, Charlson comorbidity score, use of diuretics, and use of NSAIDs

Selection: 4 stars Comparability: 2 stars Outcome: 3 stars

Pakpoor, 201522

England

1568/217179

Combined

69.4

5

The ICD 9 and 10 revision codes

Age, sex, calendar year of admission, region of residence, and socioeconomic status

Selection: 3 stars Comparability: 1 star Outcome: 2 stars

Singh, 201921

US

1129/21507

Combined

75.3

2.38

ICD-9-CM diagnostic code

Age, sex, hypertension, hyperlipidemia, and statin use

Selection: 3 stars Comparability: 2 stars Outcome: 3 stars

Hu, 202017

China

339/7900

M/W

50

13.36

A code: A221; ICD-9-CM code: 332

Sex, age, urbanization, typical comorbidities, and monthly income

Selection: 3 stars Comparability: 2 stars Outcome: 2 stars

Case-control study for gout and PD incidence

Alonso, 200718

UK

1052/6634

M/W

70.0/68.7

6

Computer-recorded PD with confirmation of the related paper records

Age, sex, practice, year of enrollment in the GPRD, and smoking

Selection: 3 stars Comparability: 2 stars Outcome: 2 stars

Schernhammer, 201316

Denmark

4484/22416

M/W

7

Diagnostic code and prescription of PD medication

Age, sex, and COPD

Selection: 3 stars Comparability: 1 star Outcome: 2 stars

Lai, 201423

China

3854/15416

M/W

75.0/74.0

10

ICD-9

Sex, age, diabetes, stroke, dementia, hyperlipidemia, depression, renal failure, head injury, hypertension, and polypharmacy

Selection: 3 stars Comparability: 1 star Outcome: 2 stars

Cohort study for urate and PD incidence

Weisskopf, 200724

US

84/165

M

30–55

9

Diagnostic validations for self-reported PD by treating neurologists or internists

Age, smoking, and caffeine intake

Selection: 3 stars Comparability: 2 stars Outcome: 2 stars

de Lau, 200525

Netherlands

68/4695

Combined

55–

9.4

Screened positive received a structural diagnostic workup

Age, sex, smoking, alcohol, dairy products, BMI

Selection: 3 stars Comparability: 2 stars Outcome: 3 stars

Davis, 199612

US

92/6851

M

45–68

24

By neurologists or neurosurgeons

Age, smoking

Selection: 3 stars Comparability: 1 star Outcome: 2 stars

Chen, 200927

US

95/15036

M/W

45–64

17

ICD diagnosis or self-reported PD with confirmation by movement disorder specialist

Age, sex, race, smoking, caffeine, BMI, alcohol, serum creatinine

Selection: 3 stars Comparability: 2 stars Outcome: 3 stars

Jain, 201128

US

154/5749

M/W

67–78

14

Self-report, medication, and hospitalization records

Age, smoking, race, BMI, alcohol, creatinine, diabetes, hypertension, uricosurics, EKG

Selection: 4 stars Comparability: 2 stars Outcome: 3 stars

Case-control study for urate and PD incidence

O’Reilly, 201013

US

101/504

W

68

14

Self-reported PD with confirmation by treating physicians and movement disorder specialist

Age, smoking, and caffeine

Selection: 3 stars Comparability: 2 stars Outcome: 3 stars

Winquist, 201026

US

97/57040

M/W

18–

2

Self-reported PD and reported current use of a standard PD medication

Age, gender, smoking, BMI, alcohol

Selection: 4 stars Comparability: 2 stars Outcome: 3 stars

Gao, 201629

US

388/1267

M/W

30–79

24

By treating neurologist/internists or movement disorder specialist

Age, smoking status, height, weight, presence of chronic diseases, and consumption of caffeinated coffee and alcohol, BMI

Selection: 3 stars Comparability: 2 stars Outcome: 3 stars